Search

Carrie A Rutkowski

from Royersford, PA
Age ~50
Get Report
Also known as:
Carrie Ann Rutkowski, Carrie Ann Kengor, Carrie A Kengor
Phone and address:
6 Medal Dr, Limerick, PA 19468
(610) 792-3673
Related to:
Laura L Duhon, 44Karen Carter-Cabell, 63Kenneth Cabell, 66Diane Smith
Connected to:
Alex Rutkowski, 49Arnold F Rutkowski, 85Blake S Rutkowski, 44Brunhilde H Rutkowski, 83Charmaine Rutkowski, 62Chris M Rutkowsky, 46Crystal Rutkowski, 38Dora M Rutkowski, 100Elaine C Rutkowski, 66Emil Rutkowski, 80

Carrie Rutkowski Phones & Addresses

  • 6 Medal Dr, Royersford, PA 19468 (610) 792-3673
  • Limerick, PA
  • Lansdale, PA
  • Tarentum, PA
  • Montgomery, PA

Work

Position: Private Household Service Occupations

Education

Degree: Associate degree or higher

Publications

Us Patents

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20040072788, Apr 15, 2004
Filed:
May 7, 2003
Appl. No.:
10/431657
Inventors:
Balkrishen Bhat - Carlsbad CA, US
Anne Eldrup - Encinitas CA, US
Thazha Prakash - Carlsbad CA, US
Phillip Cook - Fallbrook CA, US
Robert LaFemina - Schwenksville PA, US
Amy Simcoe - Collegeville PA, US
Carrie Rutkowski - Lansdale PA, US
Mario Valenciano - Scotch Plains NJ, US
International Classification:
A61K031/7076
A61K031/7072
US Classification:
514/046000, 514/050000
Abstract:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20040110717, Jun 10, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/250873
Inventors:
Steven Carroll - Yardley PA, US
Robert LaFemina - Schwenksville PA, US
Dawn Hall - Spring City PA, US
Amy Himmelberger - Lansdale PA, US
Lawrence Kuo - Gwynedd Valley PA, US
David Olsen - Lansdale PA, US
Carrie Rutkowski - Lansdale PA, US
Joanne Tomassini - Lower Gwynedd PA, US
Malcolm MacCoss - Freehold NJ, US
Haoyun An - Carlsbad CA, US
Balkrishen Bhat - Carlsbad CA, US
Neelima Bhat - Carlsbad CA, US
Phillip Cook - Fallbrook CA, US
Anne Eldrup - Encinitas CA, US
Thazha Prakash - Carlsbad CA, US
Marija Prhavc - Carlsbad CA, US
Charles Guinosso - Chestnut Ridge NY, US
International Classification:
A61K031/7076
A61K031/7072
A61K031/519
A61K031/513
A61K031/498
A61K031/4433
US Classification:
514/045000, 514/050000, 514/249000, 514/262100, 514/269000, 514/340000
Abstract:
The present invention provides nucleoside derivatives which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside derivatives alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside derivatives of the present invention.

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20050272676, Dec 8, 2005
Filed:
Aug 9, 2005
Appl. No.:
11/200499
Inventors:
Balkrishen Bhat - Carlsbad CA, US
Anne Eldrup - Encinitas CA, US
Thazha Prakash - Carlsbad CA, US
Phillip Cook - Fallbrook CA, US
Robert LaFemina - Schwenksville PA, US
Amy Simcoe - Collegeville PA, US
Carrie Rutkowski - Lansdale PA, US
Mario Valenciano - Scotch Plains NJ, US
International Classification:
A61K031/7076
A61K031/519
C07H019/00
C07D487/02
US Classification:
514043000, 536027200, 514265100, 544280000
Abstract:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20070275912, Nov 29, 2007
Filed:
Dec 21, 2006
Appl. No.:
11/643464
Inventors:
Balkrishen Bhat - Carlsbad CA, US
Anne Eldrup - Encinitas CA, US
Thazha Prakash - Carlsbad CA, US
Phillip Cook - Fallbrook CA, US
Robert LeFemina - Schwenksville PA, US
Amy Simcoe - Collegeville PA, US
Carrie Rutkowski - Lansdale PA, US
Mario Valenciano - Scotch Plains NJ, US
International Classification:
A61K 31/706
A61K 31/7076
A61P 31/14
C07H 19/06
C07H 19/16
US Classification:
514043000, 514046000, 514047000, 514049000, 514050000, 514051000, 536026700, 536026800, 536027130, 536027200, 536027600, 536028400, 536028530
Abstract:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20120165515, Jun 28, 2012
Filed:
Feb 2, 2007
Appl. No.:
11/701682
Inventors:
Balkrishen Bhat - Carlsbad CA, US
Anne B. Eldrup - Encinitas CA, US
Thazha P. Prakash - Carlsbad CA, US
Phillip Dan Cook - Fallbrook CA, US
Robert L. LaFemina - Schwenksville PA, US
Amy L. Simcoe - Collegeville PA, US
Carrie A. Rutkowski - Lansdale PA, US
Mario A. Valenciano - Scotch Plains NJ, US
International Classification:
C07H 19/20
US Classification:
536 2626, 536 267, 536 2674, 536 268, 536 2621
Abstract:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.

Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase

View page
US Patent:
20140309412, Oct 16, 2014
Filed:
Jun 12, 2013
Appl. No.:
13/916322
Inventors:
Balkrishen Bhat - Carlsbad CA, US
Anne B. El drup - Encinitas CA, US
Thazha P. Prakash - Carlsbad CA, US
Phillip Dan Cook - Fallbrook CA, US
Robert L. LaFemina - Schwenksville PA, US
Amy L. Simcoe - Collegeville PA, US
Carrie A. Rutkowski - Lansdale PA, US
Mario A. Valenciano - Scotch Plains NJ, US
International Classification:
C07H 17/02
US Classification:
536 268, 536 285, 536 2853
Abstract:
The present invention provides nucleoside compounds and certain derivatives thereof which are inhibitors of RNA-dependent RNA viral polymerase. These compounds are inhibitors of RNA-dependent RNA viral replication and are useful for the treatment of RNA-dependent RNA viral infection. They are particularly useful as inhibitors of hepatitis C virus (HCV) NS5B polymerase, as inhibitors of HCV replication, and/or for the treatment of hepatitis C infection. The invention also describes pharmaceutical compositions containing such nucleoside compounds alone or in combination with other agents active against RNA-dependent RNA viral infection, in particular HCV infection. Also disclosed are methods of inhibiting RNA-dependent RNA polymerase, inhibiting RNA-dependent RNA viral replication, and/or treating RNA-dependent RNA viral infection with the nucleoside compounds of the present invention.
Control profile
Carrie A Rutkowski from Royersford, PA, age ~50 Get Report